Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003297591 | SCV004007296 | pathogenic | Hereditary cancer-predisposing syndrome | 2023-05-12 | criteria provided, single submitter | clinical testing | The p.Y2281* pathogenic mutation (also known as c.6843C>A), located in coding exon 46 of the ATM gene, results from a C to A substitution at nucleotide position 6843. This changes the amino acid from a tyrosine to a stop codon within coding exon 46. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Myriad Genetics, |
RCV003455796 | SCV004189556 | pathogenic | Familial cancer of breast | 2023-11-07 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. |
Baylor Genetics | RCV003455796 | SCV004212141 | likely pathogenic | Familial cancer of breast | 2022-12-26 | criteria provided, single submitter | clinical testing |